4/11
05:32 am
ptct
PTC Therapeutics (PTCT) was upgraded by Raymond James Financial, Inc. to "moderate buy".
Low
Report
PTC Therapeutics (PTCT) was upgraded by Raymond James Financial, Inc. to "moderate buy".
4/10
09:00 am
ptct
PTC Therapeutics (PTCT) is now covered by Raymond James Financial, Inc.. They set an "outperform" rating and a $108.00 price target on the stock.
Medium
Report
PTC Therapeutics (PTCT) is now covered by Raymond James Financial, Inc.. They set an "outperform" rating and a $108.00 price target on the stock.
4/5
01:18 am
ptct
How The PTC Therapeutics (PTCT) Story Is Shifting With Sephience And DMD Uncertainty [Yahoo! Finance]
Low
Report
How The PTC Therapeutics (PTCT) Story Is Shifting With Sephience And DMD Uncertainty [Yahoo! Finance]
3/30
12:20 pm
ptct
PTC Therapeutics (PTCT) had its "hold" rating reaffirmed by Jefferies Financial Group Inc.. They now have a $76.00 price target on the stock, down from $91.00.
Low
Report
PTC Therapeutics (PTCT) had its "hold" rating reaffirmed by Jefferies Financial Group Inc.. They now have a $76.00 price target on the stock, down from $91.00.
3/26
05:49 am
ptct
PTC Therapeutics (PTCT) was upgraded by Truist Financial Corporation to "strong-buy".
Low
Report
PTC Therapeutics (PTCT) was upgraded by Truist Financial Corporation to "strong-buy".
3/25
08:30 am
ptct
PTC Therapeutics Appoints Biotech Banking Pioneer Jessica Chutter to Board of Directors
Low
Report
PTC Therapeutics Appoints Biotech Banking Pioneer Jessica Chutter to Board of Directors
3/20
07:25 am
ptct
Assessing PTC Therapeutics (PTCT) Valuation As Rare Disease Growth And Sephience Execution Shape Expectations [Yahoo! Finance]
Low
Report
Assessing PTC Therapeutics (PTCT) Valuation As Rare Disease Growth And Sephience Execution Shape Expectations [Yahoo! Finance]
3/13
04:30 pm
ptct
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/11
10:52 am
ptct
PTC Therapeutics, Inc. (PTCT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Low
Report
PTC Therapeutics, Inc. (PTCT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/10
09:07 pm
ptct
PTC Therapeutics, Inc. (PTCT) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
Medium
Report
PTC Therapeutics, Inc. (PTCT) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
3/3
10:31 am
ptct
Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing [Yahoo! Finance]
Low
Report
Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing [Yahoo! Finance]
2/27
04:09 am
ptct
Global Ferroptosis Targeting Therapy Market Opportunity Report 2026: Therapeutic Approaches, Technology Development Platforms & Clinical Trials Insights By Company, Country, Indication & Phase [Yahoo! Finance]
Low
Report
Global Ferroptosis Targeting Therapy Market Opportunity Report 2026: Therapeutic Approaches, Technology Development Platforms & Clinical Trials Insights By Company, Country, Indication & Phase [Yahoo! Finance]
2/23
08:29 am
ptct
PTC Therapeutics to Participate at Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
PTC Therapeutics to Participate at Upcoming Investor Conferences [Yahoo! Finance]
2/23
08:03 am
ptct
PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
2/23
08:00 am
ptct
PTC Therapeutics to Participate at Upcoming Investor Conferences
Low
Report
PTC Therapeutics to Participate at Upcoming Investor Conferences
2/23
07:01 am
ptct
PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
2/23
01:30 am
ptct
How Sephience Is Reshaping The Story For PTC Therapeutics (PTCT) And Analyst Expectations [Yahoo! Finance]
Low
Report
How Sephience Is Reshaping The Story For PTC Therapeutics (PTCT) And Analyst Expectations [Yahoo! Finance]
2/20
07:12 pm
ptct
PTC Therapeutics (PTCT) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
Low
Report
PTC Therapeutics (PTCT) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
2/20
03:14 pm
ptct
PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
2/20
01:32 pm
ptct
PTC Therapeutics, Inc. (PTCT) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
PTC Therapeutics, Inc. (PTCT) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/20
09:03 am
ptct
PTC Therapeutics (NASDAQ:PTCT) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
PTC Therapeutics (NASDAQ:PTCT) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
2/20
08:03 am
ptct
PTC Therapeutics (NASDAQ:PTCT) had its price target lowered by analysts at Bank of America Corporation from $97.00 to $93.00. They now have a "buy" rating on the stock.
Low
Report
PTC Therapeutics (NASDAQ:PTCT) had its price target lowered by analysts at Bank of America Corporation from $97.00 to $93.00. They now have a "buy" rating on the stock.
2/20
08:02 am
ptct
PTC Therapeutics (NASDAQ:PTCT) was given a new $86.00 price target on by analysts at Wells Fargo & Company.
Medium
Report
PTC Therapeutics (NASDAQ:PTCT) was given a new $86.00 price target on by analysts at Wells Fargo & Company.
2/20
12:16 am
ptct
PTC Therapeutics Inc (PTCT) Q4 2025 Earnings Call Highlights: Surpassing Revenue Expectations ... [Yahoo! Finance]
Medium
Report
PTC Therapeutics Inc (PTCT) Q4 2025 Earnings Call Highlights: Surpassing Revenue Expectations ... [Yahoo! Finance]
2/19
06:03 pm
ptct
PTC Therapeutics: Q4 Earnings Snapshot [Yahoo! Finance]
Medium
Report
PTC Therapeutics: Q4 Earnings Snapshot [Yahoo! Finance]